3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Mesothelioma
1
Interventions
pembrolizumab
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gemcitabine
2
Cisplatin
2
niraparib
1
dostarlimab
1
defactinib
1
Vitamin B 12
1
TroVax
1
Thiostrepton
1
Sorafenib
1
Pemetrexed
1
Oxaliplatin
1
Nivolumab
1
Mitomycin
1
MAC321
1
Leucovorin
1
Immunotherapy, Adoptive
1
Imatinib Mesylate
1
IPI-549
1
Folic Acid
1
Dexamethasone
1
Cytoreduction Surgical Procedures
1
Bortezomib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Mesothelioma
×
MAC321
×
Clear all
NCT00685204
2008-05-28
TL139
Taxolog Inc.
Phase 2
Unknown
90 enrolled